Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3cm in potentially transplantable patients

January 2019

Author(s): Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, et al

Details: J Hepatol. 2019

NIHR Acknowledged: Yes